ATHE

Alterity Therapeutics (ATHE)

About Alterity Therapeutics (ATHE)

Alterity Therapeutics Ltd. is a clinical stage biotechnology company. It engages in the business of research and development of therapeutic drugs designed to treat the underlying cause of degeneration of the brain focusing on Alzheimer's, Huntington, Parkinson’s, and other neurological disorders. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Melbourne, Australia.

Details

Daily high

$3.12

Daily low

$3.03

Price at open

$3.04

52 Week High

$7.00

52 Week Low

$2.20

Market cap

56.0M

Dividend yield

0.00%

Volume

5,924

Avg. volume

15,907

P/E ratio

-4.15

Alterity Therapeutics News